Home > Oncology > ASCO 2019 > Head and Neck Cancer > Sentinel lymph node biopsy shows promise for early oral cancer

Sentinel lymph node biopsy shows promise for early oral cancer

Presented By
Dr Yasuhisa Hasegawa, Asahi University Hospital, Japan
Conference
ASCO 2019
Medical writer: Michelle Dalton, ELS Sentinel lymph node biopsy (SNB)–navigated neck dissection (ND) could replace elective ND without survival disadvantage and reduce postoperative disability of the neck in patients with early-stage oral cancer, according to results from a Japanese study (Abstract 6007). During his presentation, Yasuhisa Hasegawa, MD, PhD, of Asahi University Hospital, in Japan, said that another recent study identified a survival benefit with prophylactic ND at the time of primary surgery compared with a “wait and see” approach followed by therapeutic ND for nodal relapse in patients with early-stage oral squamous cell carcinoma. In this trial, the eligibility criteria included histologically confirmed squamous cell carcinoma in the oral cavity that were classified as clinical categories T1 and T2, N0M0 by the Union for International Cancer Control (UICC) TNM classification 7th edition. The clinical depth of invasion of T1 disease ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on